Richard I. Gregory

Richard I. Gregory

Top Cited Scholar 2025
Auto-generated profile, based on publicly available information

Richard I. Gregory

Stem Cell Program Boston Children's Hospital 02115 Boston MA USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2015 in Nature Reviews Cancer
Verified
Journal Article
Closed access
PDF file
SLShuibin Lin
Shuibin Lin
RGRichard I. Gregory
Richard I. Gregory

1 May 2016 in Molecular Cell
Verified
Journal Article
Closed access
SLShuibin Lin
Shuibin Lin
JCJunho Choe
Junho Choe
PDPeng Du
Peng Du
RTRobinson Triboulet
Robinson Triboulet
RGRichard I. Gregory
Richard I. Gregory

4 April 2008 in Science
Verified
Journal Article
Closed access
PDF file
SVSrinivas R. Viswanathan
Srinivas R. Viswanathan
GDGeorge Q. Daley
George Q. Daley
RGRichard I. Gregory
Richard I. Gregory
MicroRNAs (miRNAs) play critical roles in development, and dysregulation of miRNA expression has been observed in human malignancies. Recent evidence suggests that the processing of several primary miRNA transcripts (pri-miRNAs) is blocked posttranscriptionally in embryonic stem cells, embryonal carcinoma cells, and primary tumors. Here we show that Lin28, a developmentally regulated RNA binding protein, selectively blocks the processing of pri-let-7 miRNAs in embryonic cells. Using in vitro and in vivo studies, we found that Lin28 is necessary and sufficient for blocking Microprocessor-mediated cleavage of pri-let-7 miRNAs. Our results identify Lin28 as a negative regulator of miRNA biogenesis and suggest that Lin28 may play a central role in blocking miRNA-mediated differentiation in stem cells and in certain cancers.

19 September 2018 in Nature
Verified
Journal Article
Closed access
PDF file
JCJunho Choe
Junho Choe
SLShuibin Lin
Shuibin Lin
Wencai ZhangWencai Zhang
Wencai Zhang
QLQi Liu
Qi Liu
LWLongfei Wang
Longfei Wang
RGRichard I. Gregory
Richard I. Gregory

1 November 2011 in Cell
Verified
Journal Article
Closed access
EPElena Piskounova
Elena Piskounova
CPChristos Polytarchou
Christos Polytarchou
JTJames E. Thornton
James E. Thornton
RLRobert J. LaPierre
Robert J. LaPierre
CPCharalabos Pothoulakis
Charalabos Pothoulakis
RGRichard I. Gregory
Richard I. Gregory

27 August 2009 in Nature Structural & Molecular Biology
Verified
Journal Article
Open access
PDF file
JHJohn Hagan
John Hagan
EPElena Piskounova
Elena Piskounova
RGRichard I Gregory
Richard I Gregory
The let-7 microRNA has been implicated in development and disease. Its expression must thus be tightly regulated, and previously uridylation and Lin28 were implicated in let-7 stability. Zcchc11 is now shown to be the uridylase that mediates pre–let-7 modification and regulates mature let-7 levels and activity in mouse embryonic stem cells. Lin28 and Lin28B, two developmentally regulated RNA-binding proteins and likely proto-oncogenes, selectively inhibit the maturation of let-7 family microRNAs (miRNAs) in embryonic stem cells and certain cancer cell lines. Moreover, let-7 precursors (pre–let-7) were previously found to be terminally uridylated in a Lin28-dependent fashion. Here we identify Zcchc11 (zinc finger, CCHC domain containing 11) as the 3′ terminal uridylyl transferase (TUTase) responsible for Lin28-mediated pre–let-7 uridylation and subsequent blockade of let-7 processing in mouse embryonic stem cells. We demonstrate that Zcchc11 activity is UTP-dependent, selective for let-7 and recruited by Lin28. Furthermore, knockdown of either Zcchc11 or Lin28, or overexpression of a catalytically inactive TUTase, relieves the selective inhibition of let-7 processing and leads to the accumulation of mature let-7 miRNAs and repression of let-7 target reporter genes. Our results establish a role for Zcchc11-catalyzed pre–let-7 uridylation in the control of miRNA biogenesis.